July 25 – 26, 2024
Troutman Pepper is proud to sponsor the 11th Annual Summit on Women Leaders in Life Sciences Law presented by the American Conference Institute (ACI), on July 25 – 26, 2024, in Boston, MA.
Partner Halli Cohn will be presenting on "Life Sciences in the News: Exploring the Anticipated Compliance and Litigation Risks Associated with Semaglutide and GLP-1s," on July 26 at 1:45 p.m.
The session will spotlight breakthrough 'weight loss drugs' such as Ozempic and Wegovy.
As these innovative pharmaceuticals garner attention in the media and medical communities alike, it's crucial to explore the anticipated compliance and litigation risks accompanying their introduction into the market.
- Gain insights into the latest advancements in weight loss drugs, including the mechanisms of action, clinical efficacy, and regulatory approval processes.
- Explore the versatile applications of these drugs beyond weight loss.
- Assess the profound and continued impact of these drugs on the life sciences industry.
- Review strategies for ensuring compliance with FDA regulations, labeling requirements, and marketing practices.
- Examine potential litigation risks associated with these, including allegations of adverse side effects, inadequate warnings, and product liability claims.
ACI's Summit for Women Leaders in Life Sciences law is dedicated to providing the invaluable opportunities for networking and collaboration with the chance to meet, engage with and learn from nearly 200 female attorneys and executives from the biotech, pharmaceutical, and medical device industries and keep you up-to-date on the latest developments and challenges in the industry.